In particular, as precursor substances, betulin derivatives (13, 15) were substituted with a sulfonamide (13b, 15b) to combine the cytotoxic effects of betulin/betulinic acid under hypoxic conditions with the possibility of targeting the tumor-associated and hypoxia-regulated proteins CA IX and CA XII. Here, CA9 is linked to neoplasm.